Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pipamperone add-on to risperidone or paliperidone in chronic schizophrenia or schizoaffective disorder
2011-004494-81Phase 2Terminated
- Sponsor
- PharmaNeuroBoost
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in schizophrenia and schizoaffective disorder comparing Pipamperone add-on with Placebo add-on (2 arms). Primary endpoint: Functional magnetic resonance imaging. Started Nov 2011; status: terminated.
02
Drugs
pipamperone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on 2011-004494-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004494-81.